AdvaMedDx held a briefing on Capitol Hill on March 3, 2016.
New and potentially dangerous infectious diseases emerge every year and pose an ongoing threat to the health of all Americans. Despite remarkable efforts to prepare for and address them, changes in society and the environment as well as ease of travel and increasing globalization have added complexities in containing infectious diseases that have major public health and economic implications.
If you missed the event, it can be viewed here.
The panelists, listed below, discussed how patients and the public can be protected from infectious disease threats:
- Beth Bell, MD, MPH, Director of the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention
- Steven Binder, Senior Director of Technology Development, Clinical Diagnostics Group, Bio-Rad Laboratories
- Kimberly Hanson, MD, MHS, Infectious Diseases Physician, University of Utah, Director of Clinical Microbiology, ARUP Laboratories, Infectious Diseases Society of America Diagnostics Task Force Member
- Carole Moss, Chief Financial Officer and Co-Founder, Nile's Project